Liquidity and Financial Condition (Details Narrative) - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 25, 2021	Dec. 31, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Relief funds					$ 12,500,000
Revenue recognized amount					12,400,000
Revenue recognized	$ 500,000	$ 7,500,000	$ 2,500,000		4,400,000	$ 8,000,000.0
Working capital		54,300,000
Stockholders deficit	37,509,709	41,340,429	52,911,746	$ 40,540,193	37,509,709	40,540,193		$ 49,017,752	$ 61,315,239	$ 82,286,499	$ 76,519,721
Loss from continuing operations	$ 2,400,000			$ 4,200,000	10,200,000	11,300,000
Cash used in operating activities					5,689,943	$ 13,522,634
Advanced Molecular Services Group And Health Technology Solutions Inc [Member] \| Visual M E D [Member]
Disposal Group, Including Discontinued Operation, Liabilities							$ 2,200,000
Advanced Molecular Services Group And Health Technology Solutions Inc [Member] \| Visual M E D [Member] \| Series B Preferred Stock [Member]
Disposal Group, Including Discontinued Operation, Consideration							$ 9,100,000
Paycheck Protection Program Loan [Member]
Revenue recognized			$ 100,000
Public Health And Social Services Emergency Fund [Member]
Relief funds					$ 100,000,000,000
Provider Relief Funds [Member]
Revenue recognized		$ 1,900,000